Mapro Industries Intrinsic Value
Mapro Industries (MAPROIN) median intrinsic value is ₹7.85 from 6 valuation models (range ₹8–₹33), vs current price ₹26.18 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read MAPROIN dividend yield for the complete payout history and dividend yield track record.
MAPROIN Valuation Methods Summary — DCF, Graham Number & P/E
Mapro Industries intrinsic value across 6 models vs current price ₹26.18 — upside/downside and value range per method. For current market price and key ratios, visit Mapro Industries screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹7.85 | ₹6.28 - ₹9.42 | -70.0% | EPS: ₹0.04, Sector P/E: 12x |
| Book Value Method | asset | ₹32.50 | ₹29.25 - ₹35.75 | +24.1% | Book Value/Share: ₹32.50, P/B: 1.0x |
| Simple DCF (5Y) | dcf | ₹11.60 | ₹9.28 - ₹13.92 | -55.7% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹7.85 | ₹7.06 - ₹8.63 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹7.85 | ₹7.06 - ₹8.63 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹7.85 | ₹7.06 - ₹8.63 | -70.0% | EPS: ₹0.04, BVPS: ₹32.50 |
MAPROIN Intrinsic Value vs Market Price — All Valuation Models
Mapro Industries fair value range ₹8–₹33 vs current market price ₹26.18 across 6 valuation models. Analyse MAPROIN shareholding pattern to track promoter, FII and institutional holdings.
MAPROIN Intrinsic Value Analysis — Undervalued or Overvalued?
Mapro Industries median intrinsic value ₹7.85, current price ₹26.18 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of MAPROIN?
Based on our comprehensive analysis using 6 different valuation methods, the estimated intrinsic value of Mapro Industries (MAPROIN) is ₹7.85 (median value). With the current market price of ₹26.18, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹7.85 to ₹32.50, indicating ₹7.85 - ₹32.50.
Is MAPROIN undervalued or overvalued?
Based on our multi-method analysis, Mapro Industries (MAPROIN) appears to be trading above calculated value by approximately 70.0%.
MAPROIN Financial Health — Key Ratios vs Industry Benchmarks
Mapro Industries financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | -588.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
MAPROIN Cash Flow Quality — Operating & Free Cash Flow
Mapro Industries operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2020 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2019 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |